Effects of magnesium sulfate on lipid peroxidation and blood pressure regulators in preeclampsia

OBJECTIVES

To investigate the status of lipid peroxidation and serum levels of several vasoactive substances in preeclamptic (PE) pregnant women before and during treatment with magnesium sulfate (MgSO(4)).

DESIGN AND METHODS

The study population included 16 PE women. Circulating levels of malondialdehyde (MDA), endothelin 1 (ET-1), nitric oxide (NO) metabolites, and calcitonin gene-related peptide (CGRP) were measured before (at admission) and during MgSO(4) treatment (at delivery and 24 h postpartum).

RESULTS

At admission systolic and diastolic blood pressures were 157 +/- 3 mm Hg and 106 +/- 2 mm Hg, respectively, and decreased significantly during treatment at delivery and 24 h postpartum (P < 0.0001). Before treatment, serum MDA concentrations were 0.383 +/- 0.037 micromol/L, and decreased significantly during MgSO(4) administration at delivery and 24 h postpartum (P < 0.0001). In contrast, serum ET-1 levels at 24 h postpartum were significantly higher as compared with those observed before treatment (79 +/- 3 versus 65 +/- 2 pg/mL, P = 0.002). Serum NO metabolite concentrations were 26 +/- 3 micromol/L, and no significant changes were observed during treatment. Serum levels of CGRP were 50 +/- 3 pg/mL at admission, and increased significantly at partum (P < 0.001). Serum ET-1 correlated negatively with NO metabolites before treatment (r = -0.69, P = 0.002), but not during treatment. In contrast, ET-1 correlated positively with serum CGRP levels during treatment (r = 0.73, P = 0.002 and r = 0.71, P = 0.002, at delivery and 24 h postpartum, respectively), but not before treatment.

CONCLUSIONS

This study demonstrates that MgSO(4) administration to PE pregnant women induced significant changes in lipid peroxidation, production of ET-1 and CGRP.

[Assay validation for determining nitrites and nitrates in biological fluids]

INTRODUCTION

Nitric oxide is an important modulator of numerous physiological and pathophysiological processes. An indirect form to detect NO production has been the quantification of its stable end products, nitrites and nitrates (NO2- + NO3-). These metabolites can be detected with a commercial kit, but it is somewhat expensive and not accessible to some laboratories in our country.

OBJECTIVE

To validate an easy, accessible and less expensive assay for detecting nitrates and nitrites in biological fluids.

MATERIAL AND METHODS

In this study we determined nitrates and nitrites by reducing nitrates enzymatically with nitrate reductase, followed by nitrites quantification using the Griess reagent. To validate the assay, NO3- concentration was evaluated in aliquots with known amounts of sodium nitrate, also NO2- + NO3- concentrations were detected in plasma containing known amounts of sodium nitrate, finally NO2- + NO3- levels were evaluated in plasma (n = 17) and ascites (n = 11) samples of cirrhotic patients. In samples of patients, NO2- + NO3- levels were also detected by using a commercial kit.

RESULTS

The assay that we describe here detects nitrates in the range between 25 to 400 microM/L and nitrites between 25 to 100 microM/L. When specific concentrations of nitrates were added to plasma samples, the recovery percentage in most cases was greater than 95%. In plasma samples of cirrhotic patients, average concentrations of NO2- + NO3- was 44.6 +/- 22.4 microM (mean +/- SD), similar to that found using the commercial kit, 40.9 +/- 18.3 microM/L (p = 0.107). In ascitis samples, similar results using both methods were seen, 64.5 +/- 42.0 vs. 58.2 +/- 39.3 microM/L (p = 0.172) respectively.

CONCLUSIONS

Our results suggest that the method described here could be considered as an alternative instead of commercial kits to determine NO2- + NO3- in plasma and ascites samples. In addition, this assay results more attractive because, it does not, require special equipment, it is very accessible to most laboratories, it may be use to assay one or more samples at any given time, but the most important advantage, is its cost effectiveness; thus each sample determination is about one fifth of the cost using the commercial kit.